Charmacy Pharmaceutical Co., Ltd. (HKG:2289)

Market Cap	628.56M -25.2%
Revenue (ttm)	4.88B -1.1%
Net Income	51.49M -13.2%
EPS	0.48 -13.2%
Shares Out	108.00M
PE Ratio	12.21
Forward PE	n/a
Dividend	0.34 (5.91%)
Ex-Dividend Date	May 26, 2025

Volume	500
Average Volume	25
Open	5.82
Previous Close	5.81
Day's Range	5.82 - 5.82
52-Week Range	4.30 - 7.75
Beta	-0.90
RSI	36.95
Earnings Date	Mar 27, 2026

About Charmacy Pharmaceutical

Charmacy Pharmaceutical Co., Ltd. engages in the pharmaceutical distribution business in the People’s Republic of China. The company distributes western medicines, Chinese patent medicines, healthcare products, and pharmaceutical products to downstream distributors and retail terminals. It also offers pharmaceutical product related consulting services; and operates Charmacy e-Medicine, a B2B e-commerce platform to place orders online, make inquires and payments, etc. The company was formerly known as Chuangmei Pharmaceutical Co., Ltd. and chang...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1984
• Employees: 849
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2289

Financial Performance

In 2025, Charmacy Pharmaceutical's revenue was 4.38 billion, a decrease of -1.15% compared to the previous year's 4.44 billion. Earnings were 46.27 million, a decrease of -13.16%.

Financial numbers in CNY